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I. Zusammenfassung 
Messenger RNA Degradierung startet mit Deadenylierung durch den CCR4-CAF1-NOT 
Komplex und darauf folgt entweder 5’ -> 3’ oder 3’ -> 5’ mRNA-Verdau. In dem protozoen 
Parasiten T. brucei wird die Genexpression hauptsächlich auf der Ebene des mRNA-Verdaus 
kontrolliert. In dem Parasitengenom existiert CCR4 nicht und daher wird der Komplex hier 
CAF1-NOT genannt. Wie in anderen Eukaryoten ist der Komplex auf dem Gerüstprotein 
NOT1 aufgebaut, an den sich die restlichen Untereinheiten CAF1, CAF40, NOT2, NOT3/5, 
DHH1 und ein CNOT10-ähnliches Protein anlagern. Obwohl es bekannt ist, dass CAF1 die 
katalytische Untereinheit ist, sind die Funktion der anderen Untereinheiten unbekannt. 
 
Während meiner Doktorarbeit habe ich mich auf die Charakterisierung von TbCNOT10 
konzentriert; kodiert durch den Genlokus Tb927.10.8720. In Trypanosomen ist TbCNOT10 
ungefähr 20 kDa kleiner als sein menschlicher Gegenpart und hat nur eine Sequenzidentität 
von rund 22 %. Ich konnte zeigen, dass TbCNOT10 ein stabiler Bestandteil des Komplexes 
ist und direkt mit CAF1 und NOT1 interagiert. Reduzierung von TbCNOT10 führte zu einen 
Vermehrungsdefekt des Parasiten in beiden Lebensstadien und interessanterweise, 
destabilisierte den CAF1-NOT Komplex. Als ich den RNAi-Effekt von TbCNOT10 weiter 
studierte, konnte ich sehen, dass seine Reduzierung zu einer Verringerung der NOT1 Menge 
führte und dass sich CAF1 vom Komplex ablöste. Durch die Verwendung von RNA-
Sequenzierung, um die transkriptomweite mRNA-Degradation zu messen, konnte ich in 
TbCNOT10 sowie in CAF1 armen Zellen beobachten, dass die mRNA-Degradierung stoppte. 
Einen ähnlichen Effekt konnte ich für RRP45 RNAi erkennen, während ein Knockdown von 
PAN2 das Transkriptom nicht beeinträchtigte. In vivo Bindungsassays mit CAF1 und einem 
mRNA-Reporter in TbCNOT10 armen Zellen zeigte, dass die CAF1 Aktivität vom Komplex 
unabhängig ist. Studien in Säugetierzellen zeigten, dass menschliches CNOT10 nicht für die 
Assoziation von CAF1a mit NOT1 benötigt wird. Meine Ergebnisse lassen vermuten, dass 
TbCNOT10 in Trypanosomen für die Bindung von CAF1 mit dem Komplex benötigt wird und 
dass CAF1 alleine unfähig ist, Poly(A)-binding protein (PABP) geschützte mRNAs zu 
deadenylieren. 
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II. Summary 
mRNA degradation starts with deadenylation by the CCR4-CAF1-NOT complex, which is 
followed by either 5'->3' or 3'->5' digestion. In the protozoan parasite T. brucei, gene 
expression is controlled mainly at the level of mRNA degradation. In this parasite, CCR4 is 
absent and hence the complex is called CAF1-NOT. As in other eukaryotes, the complex is 
built on the scaffold protein NOT1, to which are attached the remaining subunits: CAF1, 
CAF40, NOT2, NOT3/5, TbDHH1 and a CNOT10-like protein. Although it is clear that CAF1 
is the catalytic subunit, the functions of the other subunits are unknown. 
 
During my PhD, I focused on the characterization of TbCNOT10, encoded by the gene 
locus Tb927.10.8720. TbCNOT10 is around 20 kDa smaller than its human counterpart and 
has a sequence identity of only about 22 %. I could show that TbCNOT10 is a stable 
component of the complex and interacts directly with CAF1 and NOT1. Depletion of 
TbCNOT10 led to a proliferation defect in both life stages of the parasite and, more 
interestingly, destabilized the CAF1-NOT complex. When I further investigated the effect of 
TbCNOT10 RNAi, I could see that its depletion led to a decrease in NOT1 abundance and 
detachment of CAF1 from the complex. Using RNA sequencing to measure transcriptome-
wide RNA degradation, I observed that mRNA degradation came to a halt in TbCNOT10- and 
CAF1-depleted cells. A similar effect could be observed for RRP45 RNAi, whereas a knock 
down of PAN2 did not affect the transcriptome. Tethering assays in vivo with CAF1 and an 
mRNA reporter in TbCNOT10-depleted cells showed that the activity of CAF1 is complex-
independent. Studies in mammalian cells demonstrated that human CNOT10 is not required 
for the association of CAF1a with NOT1. Finally, my results suggest that in trypanosomes, 
CNOT10 is needed for the attachment of CAF1 with the complex and that CAF1 alone is 
unable to deadenylate Poly(A)-binding protein (PABP) protected mRNAs. 
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III. Introduction 
In this study, I use the model organism Trypanosoma brucei in order to 
investigate the role of the putative CNOT10 homologue in the process of 
mRNA turnover.  
 
III.1. The role of mRNA degradation 
Messenger RNA (mRNA) degradation is important in the control of gene 
expression. It regulates the level of mRNA transcripts and hence helps to 
define the amounts of translated proteins. If mRNA degradation is 
deregulated, it can lead to a variety of different diseases like cancer (1-4), 
chronic inflammation (e.g. arthritis) (3-5), neurodegenerative disease (6). 
 
III.2. Life and death of an mRNA 
In all organisms, messenger RNAs (mRNAs) are the carriers of genetic 
information from the nucleus into the cytoplasm. Figure 1 shows an overview 
of the different pathways an mRNA can follow. Transcription, processing and 
export determine the steady-state level of mRNAs. However, another major 
determiner of the amount of transcripts in the cell is mRNA turnover.  
Transcriptome-wide studies measuring mRNA turnover through the use of 
microarrays or RNAseq, showed major differences in mRNA half-lives 
between analysed organisms. In prokaryotes for instance, the median half-life 
was 5 min (7), whereas for the simple eukaryotes Trypanosoma brucei (T. 
brucei) and yeast, a median half-life of respectively 13 min and 21 min was 
obtained (8-10). Longer median half-lives lasting from 4 to 10 hours were 
yielded for different types of mammalian cells (11-13), and Arabidopsis also 
showed a median half-life of 3.8 h (14). The common point between all these 
studies was that related groups of mRNAs exhibited similar mRNA half-lives.  
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Figure 1 Fate of an mRNA in eukaryotes 
An mRNA can follow several different pathways once it is transcribed. The first step is 
processing and polyadenylation, which is then followed by the transport of the mRNA from the 
nucleus to the cytoplasm. Here the mRNA is either translated or targeted for degradation. The 
first step of degradation is the removal of the poly(A) tail which leads to decapping. Now 
mRNAs can be degraded by XRN1, or the exosome (Taken from 15).  
 
In the 3’UTR of mRNAs, stabilising but also destabilising elements have 
evolved in order to control the half-life of an mRNA. The 5’ end of every 
mRNA is protected by a cap structure along with the cap-binding protein 
eIF4E that prevents mRNA degradation by 5’ exoribonucleases. There is also 
a poly(A) tail with protective poly(A) binding proteins at the 3’ end to ensure a 
certain protection from 3’ exoribonucleases. To further defend the coding 
sequence (CDS) from exonucleolytic attacks and increase the rate of its 
translation, mRNAs can form a loop structure by the interaction of eIF4E with 
PABP through eIF4G (16-18). For proper gene expression, it is also essential 
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 5 
that no longer necessary mRNAs can easily be targeted to mRNA 
degradation. Therefore, cis-acting elements have evolved in the 
3’untranslated region (UTR) of mRNAs. One of the most prominent members 
is the AU-rich element (ARE), which promotes rapid degradation. This 
element can be found in many mRNAs encoding for proteins that are 
important for growth or for the response to inflammations (19, 20). Besides 
destabilising elements, there are also elements that can lead to the 
stabilisation of mRNAs (e.g. nucleolin-binding element for beta-globin 
stabilisation) (21).  
It is widely accepted that deadenylation is the initial step of mRNA decay 
(22, 23). The current model suggests that in yeast and mammalian cells the 
PAN2-PAN3 complex is responsible for the initial shortening of the poly(A) tail 
and is followed by the major deadenylation complex CCR4-CAF1-NOT (23-
26). The CCR4-CAF1-NOT complex deadenylates the poly(A) tail under a 
certain threshold (10 nt), which is below the minimum sequence length for 
PABP binding (12 – 14 nt) and hence leads to dissociation of PABP (27-29). 
By doing so, the interaction between the 3’ and 5’ end of the mRNA becomes 
disrupted, which leads to a cleavage of the protective cap structure by DCP2 
along with DCP1 (30, 31). In human and Drosophila, it was shown that Pat1 
links deadenylation and decapping by interacting simultaneously with the 
decapping complex DCP1-DCP2 and the CCR4-CAF1-NOT complex (32, 33). 
It also interacts with the Lsm1-7 proteins, Edc1-3, Hedls and the 5′-3′ 
exoribonuclease XRN1 (33, 34). However, some mRNAs are decapped in a 
deadenylation-independent manner, as for instance mRNAs with a premature 
termination codon (35) or histone mRNAs from mammalian cells lacking a 
poly (A) tail (36). The unprotected mRNA can be degraded either from the 5’ 
end by XRN1 or by the exosome and the decapping scavenger in the 3’ 
direction (22). It was recently shown that degradation by XRN1 could also 
occur co-translationally, allowing ribosomes to finish their round of translation 
(37). The upcoming sub-chapters will focus on the above-mentioned enzymes 
and the way they function in the process of mRNA turnover. 
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III.3. Deadenylation complexes 
As stated previously, mRNA degradation starts with deadenylation. In 
eukaryotes, three deadenylase complexes have been described: the poly(A)-
specific ribonuclease (PARN) that forms homodimers, PAN2-PAN3 and the 
CCR4-CAF1-NOT complex, also called CAF1-NOT, due to the absence of 
CCR4 (38, 39). 
 
III.3.1. The poly(A)-specific ribonuclease PARN 
The poly(A)-specific ribonuclease (PARN) belongs to the group of DEDD 
exonucleases. It was localised in the nucleus (cajal body and nucleoli) and in 
discrete foci in the cytoplasm in mammalian cells and plants (40-42). PARN 
differs from all other deadenylases in the fact that it is stimulated by its 
interaction with the cap structure of mRNAs (43, 44). The nuclease activity 
was confirmed in mammalian in vitro decay systems, with mRNAs possessing 
or lacking a cap structure (45-47). So far, it was shown that it functions in the 
maturation of Xenopus as well as mouse oocytes and plant embryogenesis 
(42, 48, 49). For instance, in Xenopus oocytes, it is responsible for the 
deadenylation of dormant mRNAs (e.g. cyclin B1) without inducing mRNA 
degradation. During maturation, PARN activity is inhibited and dormant 
mRNAs are polyadenylated by Gld-2, a poly(A) polymerase, in order to be 
translated (50). Additionally, PARN is essential for a proper stress response in 
Arabidopsis (51, 52). In mammalian cells, PARN could also be implicated in 
nonsense-mediated decay (53), decay of mRNAs containing AU-rich 
elements (41) and processing of snoRNA and scaRNA (40).  
 
III.3.2. PAN2-PAN3 complex 
The PAN2-PAN3 complex consists of the deadenylase PAN2 and its 
auxiliary protein PAN3. Like PARN, PAN2 belongs to the DEDD 
exonucleases. PAN3 interacts via its C-terminal part with PAN2 and with 
PABP through a PAM2 motif in its N-terminal part (54-56). The PAN2-PAN3 
complex is stimulated by PABP (54, 57). Both in yeast and in trypanosomes, 
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the complex is located in the nucleus and cytoplasm (25, 26, 58), whereas in 
human cell lines, it could only be detected in the cytoplasm (54).  
Most of the studies to characterise the PAN2-PAN3 complex were done in 
yeast. Here it was shown that a deletion of both proteins had no effect on the 
viability of S. cerevisiae (59, 60). However, longer poly(A) tails were observed 
upon deletion of PAN2 and PAN3. In the nucleus, the PAN2-PAN3 complex 
trims newly transcribed mRNAs to a specific length (25), whereas in the 
cytoplasm it is involved in the initial shortening of the poly(A) tail (25, 26). The 
implication of the PAN2-PAN3 complex with the initiation of deadenylation 
was also seen in mammalian cells (24). In Drosophila Schneider cells, the 
roles of PAN2 and CAF1 were studied in knockdown mutants, using a pulse 
chase approach. mRNA deadenylation of endogenous hsp70 was studied 
after heat shock. A knockdown of PAN2 alone had no effect, whereas 
knocking down CAF1 led to an inhibition of hsp70 deadenylation. This effect 
was increased when both were knocked down (61). In mammalian cells, the 
PAN2-PAN3 complex was found in P bodies and it was shown that PAN3 
could enhance the localisation of the deadenylases PAN2, CCR4 and CAF1 
(62). Using coimunoprecipitation and in vitro pull-down assays, human 
GW182 proteins were found to recruit PAN2-PAN3 through direct interaction 
with PAN3 (63). 
 
III.3.3. CCR4-CAF1-NOT complex 
The CCR4-CAF1-NOT complex, also known as the CAF1-NOT complex, 
is considered to be the major deadenylation complex in eukaryotes. Beside its 
role in deadenylation, it has also been implicated in the regulation of 
transcription, translation repression, the DNA damage response, mRNA 
export and nuclear surveillance (64).  
In yeast, the complex consists of nine core subunits, Ccr4p, CAF1p, 
Caf40p, CAF130p and Not 1-5p, which can alternatively form two 
distinguishable subcomplexes of 1 and 2 MDa (65, 66). The smaller complex 
consists of Not2-5p and the bigger of Not1p, Ccr4p, CAF1p, Caf40p and 
CAF130p. Figure 2 shows a comparison of the CCR4-CAF1-NOT complex in 
yeast and the CAF1-NOT complex from trypanosomes. The structure and 
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composition of the NOT complex are based on glycerol gradient centrifugation 
studies and pulldown experiments. As a result, the illustrations are merely 
estimations and probably do not reflect reality but nevertheless help to 
understand the functions of the complex. 
 
 
Figure 2 Comparison of the Ccr4-CAF1-Not complex in yeast and the 
CAF1-NOT complex of Trypanosoma brucei 
The figure shows a simplified illustration of the Ccr4-Caf1-Not complex in yeast and the 
CAF1-NOT complex in Trypanosoma brucei in which homologous subunits are shown in the 
same colour. Because CNOT10 and CAF130p are potential homologues, both are shown in 
orange. NOT1 is the major scaffold to which the remaining subunits attach themselves. CCR4 
and CAF1 are deadenylases of the complexes though Ccr4 is absent from the genome of 
trypanosomes. CAF16p and Not4p also do not have any obvious orthologues in the genome 
of T. brucei. DHH1 is a helicase and Not4p is an E3 ligase. The functions of the other 
subunits are unclear. (Figure was taken from Prof. CE Clayton and modified) 
 
In contrast to the core complex from yeast, the human, Drosophila and 
trypanosome core complexes lack Not4 and have a single protein (NOT3/5) 
that is similar to the yeast subunits Not3p and Not5p (38, 67-69). In humans, 
two additional subunits have been identified: TAB182 and C2ORF29 (67). The 
knockdown of CAF1 and CCR4 along with subsequent deadenylation 
experiments permitted to identify CAF1 as the major deadenylase in 
eukaryotes, except for yeast where it is CCR4 (38, 64, 70-72). The human 
genome contains two homologues of CAF1 (also known as CNOT7 and 8 or 
CAF1a and b) and CCR4 (CNOT6 and 6L) and these account for four 
different variants of the CCR4-CAF1-NOT complex (67, 73). All complexes 
are built on the major scaffold Not1p that acts as a platform not only for the 
Not1p
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Not5p
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remaining CCR4-CAF1-NOT core subunits, but also for specific mRNA 
degradation factors. For instance, human NOT1 is recruited to mRNAs 
containing AU-rich elements by Tis11 proteins (64, 74) and/or 
GW182/TNRC6, required for microRNA-induced mRNA decay (63, 75), which 
triggers their degradation in both cases. Due to its role as a scaffold, depletion 
of NOT1 in human and yeast led to the disruption of the complex and 
subsequently to a halt of mRNA deadenylation (76, 77). The functions of the 
other subunits Not2-5, Caf40 and CAF130/CNOT10 are unclear. 
Immunoprecipitation and gel filtration analyses with Not2p mutants in yeast 
led to the observation that Not2-5p proteins were not able to associate with 
the complex (78). In a further study in yeast, Caf40p was TAP-tagged and 
non-essential subunits of the complex were simultaneously knocked out. The 
knockout of Not2p resulted in the dissociation of CAF130p, Not4p and Not5p 
from the remaining Caf40p complex (77). In Not2 depleted mammalian cells 
the same observation could be made in gel filtration experiments (79). In 
yeast, Not3 is up to 44% identical to Not5, but in genome-wide expression 
studies using microarrays, Not3p and Not5p knockout mutants exhibit a 
specific gene expression pattern, indicating that they have distinct functions 
(77). More information is available about Not4. The human homologue of 
Not4p, CNOT4, was identified as a RING E3 ligase and NMR spectroscopy 
revealed the structure for the C4C4 RING (80). In the same study, the ubiquitin 
ligase activity could be verified in vitro. In yeast, it was shown that Not4p is 
involved in degrading aberrant polypeptides that lack a stop codon (80, 81). 
Not4p is a stable member of the CCR4-CAF1-NOT complex in yeast, but not 
in human and Drosophila (67, 68). In trypanosomes, NOT4 is absent from the 
genome (38). A crystal structure is available for Rcd-1, the human homologue 
of Caf40. It was found that Rcd-1 can dimerize and is able to bind ssDNA 
(82). CAF130p seems to be dispensable in yeast, since a CAF130p knockout 
did not influence growth and had also no effect on the transcriptome (77). It 
was shown that CAF130p interacts with the N- and C-terminus of Not1, and 
that it is not important for the stability of the complex (77, 83). Finally, very 
little is known about CNOT10. In order to figure out its role, CNOT10 was 
TAP-tagged in HeLa cells. The purification retrieved all core subunits of the 
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complex, but not the deadenylases (67). However, all these efforts failed to 
broaden our understanding of CNOT10 and detailed studies are still missing. 
 
III.3.3.1. Regulation of the major deadenylation complex 
CCR4-CAF1-NOT 
The major deadenylation complex, CCR4-CAF1-NOT, triggers mRNA 
degradation and hence it is important to control the activity of this complex. 
One level of regulation is given by the protection of the poly(A) tail, by poly(A) 
tail binding proteins (PABPs). In order to start deadenylation and trigger 
mRNA decay, PABPs need to be removed from the poly(A) tail (72, 84, 85). In 
vitro studies in yeast have shown that the CCR4-CAF1-NOT complex alone 
was not able to deadenylate mRNAs that were protected by poly(A) binding 
protein 1 (85). Thus, proteins that modulate the abundance of PABP on 
mRNAs can potentially regulate the initial step of mRNA degradation. Another 
way to control the activity of the major deadenylation complex is by preventing 
its attachment to mRNAs. Stress granules in eukaryotes were identified as 
places in the cytoplasm that do not contain deadenylases (86, 87). In addition 
to being in different places in the cell, the human NOT complex exhibits a 
tissue specific expression pattern, which might help to regulate the 
abundance of transcripts in different tissues (69, 88).  
The CCR4-CAF1-NOT complex can directly be recruited to mRNAs by a 
variety of RNA binding proteins. In human cells the complex can be recruited 
by GW182/TNRC6 to mRNAs targeted to microRNA-induced mRNA decay 
(75, 89). It was also shown that the complex could be recruited by the 
interaction of NOT1 and Tis11 proteins so as to mediate degradation of 
mRNAs with AU-rich elements (74). In yeast, PUF proteins were shown to 
recruit the CCR4-CAF1-NOT complex to mRNAs by interacting with both 
deadenylases of the complex (90-92). For instance, it is known that the RNA-
binding protein Mpt5p (PUF family member) recruits Pop2p (CAF1), Dhh1p 
and Dcp1p to HO transcripts and thereby triggers their degradation. The 
deletion of Mpt5p reduced deadenylation of HO transcripts and stabilised 
them (90). In Drosophila, studies have shown that the RNA-binding proteins 
Smaug and Nanos (both important for proper segmentation of Drosophila 
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embryos) interact with the CCR4-CAF1-NOT complex and hence trigger 
deadenylation as well as degradation of target mRNAs (93-96). Moreover, the 
RNA-binding protein Bicaudal-C (Bic-C) is required for the maternal pattering 
of Drosophila embryos. It was shown that Bic-c directly interacts with NOT3/5 
and thereby recruits the deadenylation complex to promote deadenylation 
(97). Finally, the family of BTG/Tob proteins has been implicated in the 
recruitment of the CCR4-CAF1-NOT complex (98). This family of proteins is 
unique to metazoans (98) and several of its members have been found to 
interact with CNOT7 and 8 (99, 100). 
It is important to note that these mechanisms are not mutually exclusive 
but can act together in order to control the function of the complex. 
 
III.4. XRN1 
XRN1 is a cytoplasmic exonuclease responsible for the degradation of 5’ 
monophosphorylated mRNAs. Recently the structure of XRN1 has been 
resolved for D. melanogaster (Pacman) (101) and Kluyveromyces lactis (102). 
The studies show that the active pocket from XRN1 cannot accommodate 
larger 5’ groups, which explains why XRN1 is not able to digest capped 
mRNAs. Other studies could establish that XRN1 is involved in miRNA-
induced mRNA degradation (103), small interfering RNA-mediated decay 
(104) and nonsense-mediated decay (105). In Saccharomyces cerevisiae, 
disrupting the XRN1 gene resulted in a reduced growth rate (106), an 
increased cell size as well as a variation in mRNA and protein levels (107). 
Genome-wide transcription studies using RNAseq with knockout mutants of 
XRN1 in yeast, revealed a new class of XRN1-sensitive antisense regulatory 
non-coding RNAs, called XUTs (108). A similar approach showed that XRNA, 
XRN1’s homologue in T. brucei, is involved in the degradation of unstable 
RNAs (8). 
 
III.5. Exosome 
In yeast and other eukaryotes, the exosome is a multi-protein complex that 
consists of 9 core subunits (Rrp41/Ski6, Rrp42, Rrp43, Rrp45, Rrp46, Mtr3p 
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and Rrp4, Rrp40 and Csl4), its associated catalytic subunits Dis3/Rrp44 
(endo- and exonucleolytic activity) and Rrp6 (exonucleolytic activity) (109-
112). In the nucleus of yeast, Rrp6 and Dis3/Rrp44 are associated to the 
exosome core subunits whereas in the cytoplasm, the only attached catalytic 
subunit is Dis3/Rrp44. In human, three different homologues of Rrp44 (H1, 
H2, and H3) have been identified and it is suspected that their use might vary 
(113). The core complex consists of six potential RNase-PH-like subunits 
(Rrp41/Ski6, Rrp42, Rrp43, Rrp45, Rrp46, Mtr3p), which form a ring-like 
structure and are not enzymatically active due to the lost of key residues, 
important for RNA binding or for metal and phosphate coordination (111, 113). 
The three RNA-binding proteins (Rrp4, Rrp40 and Csl4) sit as a trimeric cap 
on top of the hexameric ring (111). In the nucleus, the exosome interacts with 
other complexes (e.g. TRAMP (Trf4–Air2–Mtr4 polyadenylation) complex) and 
is involved in RNA processing, RNA surveillance and degradation of unstable 
transcripts (114, 115). In yeast, it was shown that the TRAMP complex 
polyadenylates and unwinds RNAs, which stimulates degradation by the 
exosome (114, 116). In the cytoplasm, the exosome functions mainly in 
normal and ARE-mediated decay (AMD), but is also implicated in 3’ 
degradation in no-stop decay (NSD=mRNA without termination codon), no-go 
decay (NGD=mRNA with sequence hindering ribosome translocation) and 
nonsense-mediated decay (NMD=mRNA with premature termination codon) 
(115).  
 
III.6. RNA interference and miRNAs 
RNA interference evolved in order to degrade viral RNAs and transposable 
elements, and consequently act as an innate nucleic-acid-based immune 
response (117, 118). Two main classes, siRNA and miRNA, have evolved in 
order to suppress harmful RNAs. Despite being functionally equivalent, they 
differ in their biogenesis. Micro RNAs result from transcripts in the nucleus 
that form stem-loop structures, whereas siRNA originate from long double-
stranded RNA (dsRNA) precursors. The later can be from either endogenous 
or exogenous resources (119). The process of miRNA-induced mRNA decay 
involves the binding of a small RNA (20-25 nt) protein complex (RISC) to the 
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3’UTR of their mRNA target. Besides being targeted to deadenylation followed 
by decay, mRNAs can also be repressed in translation or cleaved when 
bound by the miRNA/RISC complex, (119, 120).  
 
III.7. RNA granules: P-bodies and Stress granules 
mRNAs are coated by proteins in order to be processed, exported, 
translated or degraded. The complexes consisting of mRNAs and proteins are 
called messenger ribonuleoprotein (mRNP) complexes. In the cytoplasm, 
mRNPs that are removed from the translationally active pool are degraded in 
the 5’ direction after deadenylation in so-called processing bodies (P-bodies) 
(121). P-bodies are constitutive RNA granules that contain deadenylases, the 
5’-3’ degradation machinery, translation initiation factors and components of 
the NMD and miRNA pathways, but lack the exosome (121). For instance, 
Ccr4 was identified as a component of P-bodies and shown to be essential in 
their formation in HeLa cells (122, 123). It is also speculated that in P-bodies, 
mRNPs can be stored until further use (121, 124, 125).  
Upon stress, another type of granule can be observed in the cytoplasm of 
most eukaryotic cells, the so-called stress granules. They depend on the 
presence of P-bodies and silent mRNPs can shuttle between these foci. They 
contain the small ribosomal subunit (40 S), several translation initiation 
factors, poly(A)-binding protein and RNA-binding proteins (e.g. TIA-1), 
indicating that the contained mRNPs were stalled in translation initiation, 
before being shuttled in stress granules (126). The function of stress granules 
is not well understood yet, but they are believed to serve as storage foci for 
the duration of stress (126). 
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III.8. Trypanosomiasis 
There are two subspecies responsible for Human African Trypanosomiasis 
(HAT): T. b. gambiense and T. b. rhodesiense. HAT is also known as African 
sleeping sickness and is found in sub-Saharan Africa where more than 60 
million inhabitants are at risk of being infected. However, recent efforts to 
prevent African sleeping sickness reduced the reported cases of annual 
infections from around 50,000-70,000 to below 10,000 (127, 128, 
http://www.who.int/mediacentre/factsheets/fs259/en/, June 2012). This being 
said, it is fundamental to emphasise the fact that most cases remain 
unreported.  
The parasites are transmitted by the tsetse fly, which belongs to the family 
of Glossinidae. Upon infection the parasite first proliferates in the bloodstream 
and once a certain density is reached, it crosses the blood-brain barrier. It 
evades the host immune system through frequent changes of their surface 
coat enabled by antigenic variations of the variant surface glycoprotein (VSG). 
Clonal variants within the population of bloodstream form trypanosomes 
account for the fact that a subpopulation of T. brucei always persists 
clearance by the immune system. Once the central nervous system is 
infected, patients start to show neurological disorders and finally fall into 
coma. If the disease remains untreated, most cases will result in death.  
Up to 95% of the reported cases of African sleeping sickness are caused 
by T. b. gambiense, which is mainly found in West Africa 
(http://www.who.int/mediacentre/factsheets/fs259/en/, June 2012). The 
disease caused by T. b. gambiense leads to a chronic infection that can last 
for several years. In East Africa, the responsible causative agent is T. b. 
rhodesiense and leads to a more acute form of the disease. A third 
subspecies, named T. b. brucei, is used in laboratories since it is commonly 
not infectious for humans but mainly for game and wild animals. In this case, 
the disease is called Nagana. However, the main threat for African lifestock is 
not T. b. brucei but T. congolense and T. vivax. 
The life cycle of T. brucei starts when the Tsetse fly takes a bloodmeal 
during which the non-proliferative stumpy form of the parasite is ingested. In 
the midgut, T. brucei differentiates into the proliferative procyclic form and 
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migrates first to the proventriculus and then to the salivary glands, where it 
finally transforms into the infectious metacyclic form. During the next blood 
meal, the metacyclic parasite enters the bloodstream of its new host and 
differentiates into the long slender bloodstream form of the parasite. Once a 
certain density is reached, the parasite transforms into the short stumpy form, 
which is infectious for tsetse flies.  
 
 
Figure 3 Simplified life cycle of T. brucei brucei 
The figure shows a simplified overview of the life cycle of T. b. brucei. After reaching a certain 
density in the bloodstream of its host, the parasite differentiates from the long slender to the 
infectious short stumpy form. During the bloodmeal, the tsetse fly ingests the parasite, which 
transforms into the procyclic form in the fly’s midgut. It then migrates from the midgut to the 
salivary gland and changes there to the infectious non-proliferative metacyclic form. During 
the next blood meal, the metacyclic parasite is transmitted. (Picture taken and modified from: 
http://www.biology.ed.ac.uk/research/groups/kmatthews/index.htm, June 2012) 
 
For this study, I mainly used the monomorphic long slender bloodstream 
and procyclic form parasites for some experiments. Both can be easily 
cultured in a lab. 
 
!"#$ %&'$"(
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III.9. Gene regulation in trypanosomes 
Due to the high diversity of its environment, the parasite is obliged to 
change its gene expression rapidly in order to survive (129). Compared to 
other model organisms like yeast and Drosophila, the regulation of gene 
expression is very different in T. brucei. Protein-coding genes are arranged in 
large polycistronic units, transcribed by RNA polymerase II (130). The 
maturation of precursor mRNA includes trans splicing of the downstream 
mRNA, which is coupled with polyadenylation of the upstream mRNA (131). 
During the process of trans splicing, a capped 39 nt long spliced leader RNA 
is attach to every 5’ end. The spliced leader gene is the only gene shown to 
have a clear defined Pol II promoter and a corresponding transcription factor 
tSNAP42 (132). However, there are reports showing that some sequence loci 
(e.g. actin and HSP70) can act as promoters but the precise sequence could 
not be identified yet (133, 134). Thus, the parasite lacks transcriptional control 
and is dependent on post-transcriptional regulation mechanisms (135). 
In order to supply sufficient amounts of mRNA transcripts of highly 
expressed proteins, the genome contains several copies of certain genes 
(e.g. histone H4, tubulin etc.), and RNA polymerase I transcribes the surface 
proteins VSG (variant surface glycoprotein) and EP (procyclin) in addition to 
rDNA (136). Epigenetic mechanisms suppress all VSG copies in the genome 
except the active one (137). 
Another mechanism to control the amount of mRNA transcript in the cell is 
the use of RNA binding proteins. Several groups exist in T. brucei, which can 
bind to the cis-element(s) of their target mRNAs and thereby stabilise or 
destabilise them. The biggest group is that of RNA Recognition Motif (RRM) 
proteins. In T. brucei, this group consists of 75 proteins and each of them 
possesses one or more motifs in their amino acid sequence (138). Most of 
them have no identifiable orthologues in other eukaryotes, but are T. brucei-
specific, like RBP3 or RBP10 (139, 140). Proteins with CCCH zinc finger 
motifs bind to single stranded RNA and were found to be implicated in 
differentiation and stress response (141). PUF (Pumilio/Fem-3-binding factor)-
domain-containing proteins form one of the major known groups of RNA 
binding proteins in trypanosomes. There are at least 10 Puf proteins identified 
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in T. brucei that lead to stabilisation or destabilisation of its mRNA target or 
are involved in rRNA processing (142). For instance, PUF9 neutralises a 
destabilising mRNA element by binding to it (143) and PUF7 was shown to be 
involved in pre-rRNA processing (144). The latest identified group of RNA 
binding proteins in trypanosomes are the ALBA proteins. Four different 
proteins of this group have been identified and it was shown that they could 
interact with the translation machinery (145). Their exact function, however, is 
still unknown.  
Given the dependence of T. brucei on the post-transcriptional control 
mechanisms detailed above, the parasite reveals itself as an ideal model 
organism to study them. 
 
III.10. mRNA degradation in T. brucei 
T. brucei have most of the common mRNA degradation pathways. It was 
shown that the parasite lacks transcriptional control for protein-coding genes 
and has all-important enzymatic homologues for mRNA decay. This makes it 
an optimal model organism to study mRNA turnover. 
In the parasite, mRNA degradation starts with deadenylation (8) and cell 
extracts revealed decapping activity, but the responsible enzyme could not be 
identified so far (146). It has been shown that degradation could proceed from 
both ends (58, 147): from the 3’ direction by the exosome together with the 
decapping scavenger and from the 5’ directions by XRNA, the trypanosome 
homologue of XRN1. 
The CAF1-NOT complex was identified as the major deadenylation 
complex. A tandem affinity purification of CAF1 could pull-down NOT1, 2, 3/5 
and DHH1. Additionally, CAF130/CNOT10- and CAF16-like proteins were 
retrieved from the affinity purification. The study also revealed that T. brucei 
does not contain a homologue of CCR4. Depleting NOT1, CAF1 and DHH1 in 
bloodstream form parasites inhibited growth and led to death after 2 – 3 days 
of RNAi induction. CAF1 was identified as the major deadenylases based on 
the following observations. The knockdown of CAF1 inhibited deadenylation 
of bulk mRNAs and mRNA degradation assays showed a delayed decay of all 
analysed mRNAs. Interestingly, upon CAF1 depletion, only the steady-state 
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level of EP, an mRNA transcribed by RNA Pol I, was elevated but this was not 
the case for the investigated mRNAs, which are transcribed by RNA Pol II (38, 
58). Two different explanations have been provided to account for this fact: 
there might either be an inhibitory feedback response from RNA polymerase II 
or mRNA synthesis depends on ribonucleotides produced by mRNA 
degradation (38, 58). 
Along with the CAF1-NOT complex, the parasite has two other 
deadenylases: PAN2 and PARN-1 (58, 148). In trypanosomes, PAN2 appears 
to be essential for growth but, in contrast to yeast and mammalian cells, 
PAN2 activity in T. brucei does not seem to depend on PAN3. A knockdown 
of PAN2 did not affect the mRNA degradation kinetics of several mRNAs (58). 
It was proposed that PARN-1 participates in the regulation of stage specific 
mRNAs, but the results were not clear (148).  
The major homologue of XRN1 in T. brucei is XRNA, which plays an 
important role in 5’ – 3’ degradation, and in particular that of unstable mRNAs 
(8).  
T. brucei possesses a functional exosome that is similar to its orthologues 
in yeast and humans (149). All subunits are essential for growth and rRNA 
maturation, except RRP6. Trypanosome RRP6 is not restricted to the nucleus 
and could be detected in the cytoplasm in stoichiometric amounts (147, 150-
152). Moreover, there is no evidence of the TRAMP complex’s presence. 
Although, the trypanosome RNA helicase TbMTR4 is essential for growth and 
rRNA maturation, it does not interact with the exosome and TbNPAPL, a 
putative homologue of Trf4p, nor does it interact with other RNA-binding 
proteins. (153).  
A “classical” nonsense mediated decay (NMD) pathway still needs to be 
confirmed since experiments trying to reverse a putative NMD effect by 
depleting UPF1 have failed (154).  
 
III.11. RNA granules in T. brucei 
Trypanosomes, like other eukaryotes, possess RNA granules in their 
cytoplasm. A P-body-like structure could be identified in T. cruzi, by detecting 
XRNA and DHH1 in discrete foci (155-157). UBP1 and PUF6 were also 
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identified in the P-bodies of T. cruzi along with translation initiation factors 
(155). In T. brucei, DHH1, XRNA and SCD6 were found in discrete foci 
considered to be P-bodies. However, none of the other common P-body 
markers could be analysed due to a lack of antibodies (157). Upon heat 
shock, stress granules were identified in T. brucei and T. cruzi. In T. brucei, 
translation initiation factors eIF4E (1 to 4), eIF2α and eIF3B as well as both 
poly(A)-binding proteins PABP1 and PABP2 could be identified in discrete foci 
after stress induction (157). The role of these granules in trypanosomes is not 
well understood. 
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IV. Materials and Methods 
Some parts of this section were copied from the PhD thesis of Angela 
Schwede and Corinna Benz. 
 
IV.1. In silico experiments 
To find potential homologues of Tb927.10.8720, the protein sequence was 
analysed by BLASTp, psi-BLAST and tBLAST (158). I used standard 
parameters and excluded kinetoplastids (taxid:5653) from the search. 
Domains were identified by a SUPERFAMILY search (159). Multiple 
sequence alignments were done with ClustalW, to find conserved regions in 
protein sequences. For in silico cloning the Lasergene software package from 
DNASTAR was used. 
 
IV.2. Cell culture 
The experiments were done with bloodstream form Trypanosoma brucei 
that stably express the tetracycline repressor, with or without T7 polymerase 
expression. Culturing, transfections and RNAi experiments were conducted as 
described earlier (160). mRNA decay was analyzed after 24 hours of RNAi 
targeting CNOT10. Cells were treated with Sinefungin (final concentration 2 
µg/ ml) for 5 min, and then Actinomycin D was added to a final concentration 
of 10 µg/ml. The experiment was conducted as described in (38). 
Sahil Sharma did all experiments in human cells. HEK293 cells were cultured 
in Dulbecco's modified Eagle medium (DMEM) containing 10% fetal bovine 
serum (PAA Laboratories), 2 mM l-glutamine, 100 U/ml penicillin, and 0.1 
mg/ml streptomycin (all PAN Biotech) at 37°C/5% CO2. Cells were transfected 
with DNA using polyethyleneimine (PEI) (Polysciences Europe; 1 mg/ml, pH 
7.0) at a ratio of 1:2 (DNA:PEI) in serum-free DMEM without antibiotics. For 
transfection of siRNAs, Lipofectamine RNAimax (Invitrogen) and Optimem 
(Gibco) were used according to the manufacturer's protocol.  
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The below-mentioned siRNAs were transfected at a concentration of 100 nM 
with Lipofectamine 2000 twice over a time period of 4 days: 
 
C2/S014 (control): 5′-GGUCCGGCUCCCCCAAAUGdTdT-3′ 
S021 (CNOT1): 5′-GGAACUUGUUUGAAGAAUAdTdT-3′ 
S059 (CNOT10): 5′-CAGCGAAAGCAGTGAAACTdTdT-3′ 
 
The medium was changed to regular DMEM 4 h after transfection of DNA.  
 
IV.3. RNA extraction and Northern Blot analysis 
Total RNA was extracted using peqGold Trifast (peqLab, Germany). RNA 
was run on formaldehyde gels and blotted onto Nytran membranes (GE 
Healthcare). Northern blots were hybridized with radioactively labelled DNA 
(Prime-IT RmT Random Primer Labelling Kit, Stratagene) or RNA 
(MAXIscript, Ambion) probes (38). Northern blots used for spliced leader 
experiments, were prehybridized for 2 h at 42°C in 6xSSC, 0.5% SDS, 5x 
Denhardt, 0.05 % sodium pyrophosphate and 100 µg/ml boiled herring sperm 
DNA. For hybridization the P32 labelled anti-sense oligo of the spliced leader 
sequence cz4490 was added to the prehybridisation solution o/n at 42°C. The 
blot was first washed twice at RT for 15 min and once for 1 h with 6xSSC, 
0.05% sodium pyrophosphate, after the blot was washed for 30 min at 55°C in 
6xSSC, 0.05% sodium pyrophosphate. Signals were measured using a 
phosphorimager (Fuji, FLA7000). Either the signal of the signal recognition 
particle (7SL) or a large subunit rRNA (LSU1) was used for normalization. The 
half-lives were estimated using only the segments of the time course that 
gave exponential decay curves (fitted with a linear correlation coefficient 
generally exceeding 0.9). 
RNA used for RNAseq was treated with the RiboMinus™ Eukaryote Kit 
(Invitrogen), in order to remove the rRNA from the sample. All steps were 
done as described in the kit and eluted in 16 µl. The RNA was sent to the 
Deep Sequencing Core Facility of the Bioquant, Heidelberg. The received 
data was analysed by Abeer Fadda. 
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IV.4. Cloning 
All experiments (PCR, restriction, ligation, transformation, sequencing, 
agarose gels, etc.) necessary for cloning were conducted as described in the 
TDR/EMBO protocol or as stated in the instruction of the manufacturer. For 
restriction reactions enzymes from NEB were applied. In order to blund a 
vector, T4 polymerase from NEB was used. For dephosphorylation of 
linearised plasmids Antarctic Phosphatase (NEB) was deployed. For normal 
control/ colony PCRs GoTaq® DNA Polymerase from Promega was used and 
for all PCRs for cloning reactions Phusion® High-Fidelity DNA Polymerase 
from Finnzymes was deployed. For plasmid DNA purification and Nucleic Acid 
gel extraction the kits from Macherey-Nagel were used. To purify genomic 
DNA, I harvest around 1x108 BS trypanosomes and used the illustra™ tissue 
& cells genomicPrep Mini Spin Kit from GE Healthcare and followed the 
instructions of the manufacturer. The list of plasmids and primers used in this 
thesis is at the end of this chapter. 
 
IV.5. Co-Immunoprecipitation 
For co-Immunoprecipitation (co-IP) experiments 5x107 trypanosomes were 
lysed in co-IP-lysis buffer containing 10mM NaCl, 10mM Tris-HCl, pH7.5, 0.3 
% IGEPAL and protease inhibitors (Protease Inhibitor Mixture (EDTA-free); 
Roche Applied Science) by passing them 5 times through a 27 g syringe. To 
test RNA dependent interaction, RNaseA was added to the lysis and wash 
buffer at a concentration of 200 µg/ml and as a control recombinant RNasin® 
Ribonuclease inhibitor (Promega) at a concentration of 48 µg/ml. Afterwards 
the cells were centrifuged for 20 min at 4°C, 16 x g. 30 µl of V5 Antibody or c-
myc Antibody coupled agarose slurry (both Bethyl) were washed 4 times with 
1xPBS and once with co-IP lysis buffer adjusted to 180 mM NaCl at 4°C, 0.9 x 
g for 2.00 min. The cell supernatant was transferred into a new tube and the 
salt concentration was adjusted to 180 mM NaCl. A sample of 5x105 cells was 
taken from the input and 2x Laemmli buffer was added. Beads and cell 
lysates were incubated for one to 1.5 h at 4°C with rotation. A sample 
 Materials and Methods  
 23 
equivalent to 5x105 cells was taken from the supernatant and 2x Laemmli 
buffer was added to it. The beads were washed four times for 5 min at 4°C 
with salt-adjusted lysis buffer then boiled in 2x Laemmli buffer. 
Twenty-four hours after transient transfection, HEK293 cells from a 
confluent 10 cm dish were collected and lysed in 400 µl ice-cold RNA-IP lysis 
buffer (50 mM Tris [pH 8.0], 150 mM NaCl, 1 mM MgCl2, 2 % NP-40, 10% 
glycerol with freshly added protease inhibitors [Complete; Roche]). Nuclei 
were removed by centrifugation at 500 × g for 5 min at 4°C. A total of 30 µl of 
Streptavidin sepharose beads (GE Healthcare) were added for an additional 
1.5 - 2 h and washed six times in NET2 buffer (50 mM Tris [pH 7.5], 150 mM 
NaCl, 0.5% Triton X-100). Protein complexes were eluted with 50 µl SDS 
sample buffer with 100 mM dithiothreitol (DTT). Proteins were resolved on 5 – 
20 % gradient polyacrylamide gels and transferred onto a 0.2-µm-pore-size 
nitrocellulose membrane (Peqlab) for Western blotting. Horseradish 
peroxidase-coupled secondary antibodies (Jackson Immunoresearch) in 
combination with Western Lightning enhanced chemiluminescence substrate 
(Perkin Elmer) were used for detection. Streptavidin sepharose beads (GE 
Healthcare) were used to purify myc-Strep-tagged (myc-SG) proteins. 
 
IV.6. Two-hybrid Analysis 
Esteban Erben conducted all yeast two-hybrid experiments. Complete 
ORFs were cloned into pGADT7 (GAL4 activation domain vector) and 
pGBKT7 (GAL4 DNA-binding domain vector) (Matchmaker 3 System, 
Clontech). The two-hybrid yeast strain AH109 was then transformed with 
these plasmids in all possible combinations. The expression of the fusion 
protein was confirmed by Western blot analysis using antibodies directed 
against the HA epitope of GAL4 activation domain fusion proteins and anti c-
Myc antibody to detect GAL4 DNA-binding domain fusions. Transformants 
were selected on four drop-out SD/-Trp/-Leu/-His/-Ade culture plates after 4 
days of incubation at 30°C, and the resulting positive clones were assayed for 
β-galactosidase activity using a colony-lift filter assay. Alternatively, reporter 
activation was tested by replica plating on three drop-out SD/-Trp/-Leu/-His 
(medium stringency). As negative control for self-activation, we used a 
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combination of the Not1-complex subunits with CLONTECH vectors pGAD-T-
antigen and pGBKT7-p53. Further, p53 (pGBKT7-p53) and SV40 large T-
antigen (pGADT7-T) cotransformants were used as positive controls, whereas 
lamin C (pGBKT7-Lamin) and pGADT7-T cotransformants were used as 
negative controls. 
 
IV.7. Glycerol Gradient 
3x107 bloodstream trypanosomes or HEK293, cells from a confluent 10 cm 
dish, were washed with 1xPBS, then frozen in liquid nitrogen and stored at -
80°C until use. The cell pellets were thawed on ice and resuspended in ice-
cold buffer containing 10mM Tris-HCl, pH 7.6, 10 mM NaCl, 10 mM MgCl and 
protease inhibitors (Protease Inhibitor Mixture (EDTA-free); Roche Applied 
Science), then forced 5 times through a 27 g needle. Igepal CA-630 (Sigma) 
was added to a final concentration of 0.1% and the cells were again forced 
through the needle 5 times. The lysate was centrifuged first for 20 min at 4°C, 
10,000 x g, followed by an additional spun for 1 h at 100,000 x g at 4°C. The 
supernatant was layered onto a 12 ml 10-30% glycerol gradient  (200 mM 
KAc, 20mM Tri-HCl, pH 8,0, 5 mM MgAc, 1mM DTT and protease inhibitors 
(Protease Inhibitor Mixture (EDTA-free); Roche Applied Science), which was 
then spun at 229,900 x g for 17 h at 4°C. 27 fractions were then taken from 
the top at 23 second intervals. The fractions were incubated on ice overnight 
with 15% TCA, 0.1% DOC and 10 µg BSA. Precipitations were washed with 
acetone and resuspended in Laemmli buffer. 
 
IV.8. Tandem Affinity Purification 
In total, 2.5x1010 bloodstream trypanosomes, with in situ N-terminal 
protein-A-calmodulin-binding-peptide tagged CNOT10, were harvested and 
used for tandem affinity purification as previously described (150). The eluate 
was run one centimetre in a 10% SDS-PAGE resolving gel and stained with 
colloidal coomassie. The whole preparation was then send for mass 
spectrometry.  
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IV.9. Protein detection 
Trypanosoma BSF or HEK cells were washed once with PBS and after 
dissolved in 2X Laemmli Buffer. Protein samples were run on a SDS-PAGE 
and after blotted onto an Optitran BA-S 85 Reinforced NC 0.45 µm membrane 
(Whatman, Dassl, Germany). The Blots were probed with either Anti-V5 
(1:2000; 5% Milk in TBS-T) or Anti-myc primary Antibody (1:2000; 5% Milk in 
TBS-T) and Anti-mouse secondary Antibody (1:2000; 5% Milk in TBS-T). 
After, blots were developed with Western Lightning®-ECl solution from 
PerkinElmer. 
Immunofluoresence (IF) microscopy was conducted as described earlier in 
Schwede et al. 2008 (38).  
The following antibodies were used in Western blotting:   
Monoclonal mouse Anti-V5 (Santa Cruz), monoclonal mouse anti c-myc 
(Santa Cruz), monoclonal mouse anti GFP (Santa Cruz), ECL™Anti-Rabbit 
IgG (GE Healthcare), ECL™Anti-Mouse IgG (GE Healthcare), polyclonal 
rabbit antibodies anti-myc (A-14, sc-789, Santa Cruz), anti-CNOT10 (15938-
1-AP, Protein Tech) and anti-CNOT1 (14276-1-AP, Protein Tech). Polyclonal 
rabbit anti-CAF1a was kindly provided by Ann-Bin Shyu (University of Texas, 
Houston, TX). Polyclonal rabbit anti-PUF2 (1:2000). 
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Table 3: Primers 
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V. Results 
V.1. Tb927.10.8720 is an orthologue of CNOT10 in other 
eukaryotes 
The protein encoded by the trypanosome locus Tb927.10.8720 was 
previously identified as a potential component of the CAF1-NOT complex 
through tandem affinity purification of CAF1 (38). It was shown to be a distant 
relative of CNOT10 with poor likelihood. The CNOT10-like protein 
(TbCNOT10) in T. brucei comprises 555 amino acids and includes 
Tetratricopeptide repeat (TPR)-like domains positioned from amino acid 199-
313 and 471-550. Analyses of TbCNOT10 by reciprocal blastp and PSI-
BLAST permitted to identify more than 40 orthologues of CNOT10 in plants 
and animals with E-values ranging from 3e-04 to 1e-07. Reciprocal blastp of 
human CNOT10 (HsCNOT10) against the trypanosome genome yielded 
Tb927.10.8720 as the best match (E value 3e-04). The sequence coverage 
was between 20 – 60% and depending on the percentage of coverage, 
identities varied from 20 – 30%. Most of the hits against CNOT10 covered the 
beginning of the TPR domain of TbCNOT10 and the rest aligned to the 
beginning until the end of the TPR domain. The sequence alignment 
comparing the human and trypanosome CNOT10, made with ClustalW, is 
shown in Figure 4 along with a simplified illustration. A directed BLASTp 
search in different eukaryotic phyla and kingdoms revealed that CNOT10 
could not be detected in Apicomplexa, Diplomonadida, Alveolates and fungi. 
On the other hand, CAF130 is restricted to fungi and has no orthologues in 
other kingdoms. 
The sequence analyses suggested that Tb927.10.8720 might be an 
orthologue of CNOT10 and will consequently be called TbCNOT10 from now 
on. My next step was then to prove that TbCNOT10 is a stable member of the 
NOT complex. 
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Figure 4 Sequence alignment of human and trypanosome CNOT10 
(A) HsCNOT10 was aligned with the potential homologue of T. brucei using ClustalW. Amino 
acids that are conserved between species are shown in red. (B) shows a schematic 
sequence alignment of human and trypanosome CNOT10. The grey colour indicates the 
sequence area containing the TPR domain. The numbers represent the amino acid residue 
that corresponds to this area. (C) Sequence distance of the ClustalW alignment. 
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V.2. TbCNOT10 is a member of the CAF1-NOT 
complex in T. brucei 
To confirm that TbCNOT10 is a member of the CAF1-NOT complex, I 
conducted co-immunoprecipitations with in situ N-terminal V5-tagged 
CNOT10 (V5-CNOT10) and inducible C-terminal myc-tagged CAF1 (CAF1-
myc). The pull-down of V5-tagged CNOT10 resulted in a coprecipitation of 
CAF1-myc (Figure 5 A) and was replicable vice versa. RNase A treatment did 
not disrupt the interaction and confirmed its RNA independency (Figure 5 B). 
 
 
Figure 5 CNOT10 is a member of the CAF1-NOT complex 
(A) Immunoprecipitation of V5-CNOT10 resulted in a coprecipitation of CAF1-myc, the 
experiment was replicable vice versa. (B) myc-tagged CAF1 was pulled down in the presence 
of RNase inbibitor (-) or RNase A (+) and the Western Blot was probed to detect V5-CNOT10.  
 
In order to identify further interaction partners, I tandem affinity purified (TAP) 
CNOT10. Thus, I created a TAP-tagged CNOT10 cell line by introducing a N-
terminal TAP-tag directly upstream of the open reading frame by homologous 
recombination. The functionality of the tagged-protein was confirmed by 
knocking-out the remaining wild-type gene (Figure 6 A, A’, B-D). The cells 
were viable and did not show any morphology defects. Proteins resulting from 
the tandem affinity purification were resolved on a SDS-PAGE and analysed 
by mass spectrometry (Figure 6 E). 
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Figure 6 Tandem affinity purification of TbCNOT10 in bloodstream form 
trypanosomes 
(A) PCR primers annealing to the 5’ and 3’ UTR of TbCNOT10 were used to verify the 
integration of the N-terminal TAP-tag and the knockout of wild-type TbCNOT10. As expected, 
priming from the 5’ and 3’ UTR of TbCNOT10 generated a 2.5 kb fragment in the wild-type 
cell line; compare with (B). Two bands were visible in the single knockout cell line, one for the 
wild-type gene at 2.5 kb and a smaller one for the Hygromycin resistance at 1.8 kb; compare 
with (C). Two bands were also seen for the TAP-tag CNOT10 cell line, one strong at 1.8 kb 
for the resistance marker (Hygro) and a second one, faint, for the in situ TAP-tagged 
TbCNOT10 at 4.3 kb; compare with (D). Differences in intensity are due to the PCR bias in 
favour of smaller fragments. (A’) Priming from the 5’UTR of TbCNOT10 and reverse from the 
middle of the ORF, one band was detected; compare with (B, C and D). (E) shows a SDS-
PAGE of the tandem affinity purification of TbCNOT10, sent for mass spec. (F) shows an 
excerpt of the TAP results (the complete results can be found on the provided CD). 
 
Although the peptide coverage was very low, I could identify all core 
members of the NOT complex in the mass spectrometry results, with the 
exception of CAF1 (Figure 6 F). This result is similar to a purification done in 
human cells by Lau et al. 2009, who were also unable to pull-down CNOT6/6L 
(CCR4) and 7 (CAF1a) using TAP-tagged HsCNOT10. In contrast to an 
earlier performed TAP with CAF1 (38), I was able to observe the presence of 
CAF40. Additionally to the subunits of the complex, I could also purify two 
ATP-dependent DEAD/H RNA helicases, but these interactions could not be 
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verified due to a lack of antibodies. Another, ATP-dependent DEAD/H RNA 
helicase (Tb09.211.3510) was detected in the purification, but this helicase 
was already found several times in other TAP of our lab, which suggests that 
it is a rather common contamination due to its probable binding to the TAP-
tag. Interestingly, I was able to identify one potential nuclear pore protein, 
encoded by Tb11.01.7010, which is a putative homologue of the yeast 
karyopherins Pse1p and Kap123p. An association of some members of the 
NOT complex with nuclear pore proteins was already shown in the human 
TAP by Lau et al. 2009, (67), but it is worth mentioning that no interaction 
between HsCNOT10 and the nuclear pore proteins was identified. 
Furthermore, I could observe that the RNA-binding protein PUF2 was pulled 
down in the TAP, but co-immunoprecipitating PUF2 in a V5-tagged 
TbCNOT10 BS cell line proved unsuccessful (Figure 7). A detailed list of all 
hits can be found in the attached CD. 
 
 
Figure 7 V5-CNOT10 does not interact with PUF2 
5x107 trypanosomes expressing in situ V5-tagged TbCNOT10 were used in a co-IP to detect 
a possible interaction of TbCNOT10 and PUF2. (E=Eluate, U=unbound, I=input). 
 
In this chapter, I could establish that TbCNOT10 is a stable member of the 
CAF1-NOT complex in trypanosomes and that it might not interact with RNA 
binding proteins. In the following chapter, I attempt to show that members of 
the CAF1-NOT complex are essential for the growth of the parasite. 
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V.3. Most CAF1-NOT subunits are essential for 
the survival of trypanosomes 
To see if TbCNOT10 is essential for trypanosomes, I created permanent 
cell lines with inducible RNAi for the bloodstream and procyclic form of the 
parasite. RNAi was induced and after 36 hours, a severe proliferation defect 
could be observed in the bloodstream form of the parasite (Figure 8). In the 
slower growing procyclic form, it took about 60 hours to observe a decrease in 
cell numbers. At the same time, I also knocked down CAF16, CAF40, NOT2 
and 3/5 in BS. For NOT3/5 and CAF40 a proliferation defect was observed 
(Figure 8 C, D) that was not visible for CAF16 and NOT2 (Figure 8 E, F). I 
could not verify the efficient knock down of CAF16 since I did not detect any 
signal on the Northern blot. The rRNA might have masked the mRNA signal 
because it was at the same place. However, I did not follow up this result as 
sequence analysis of the putative CAF16 indicated that it is not a homologue 
of CAF16 in other eukaryotes, but a putative ABC transporter (TriTrypDB 
Tb927.6.2810). In the case of NOT2, the RNAi was not very efficient in all 
tested clones. A high-throughput RNAi screen done by Alsford et al. in 2011 
(161) yielded the same results, that is say, no RNAi effect could be detected. 
To verify that an RNAi efficiently reduced the protein level of TbCNOT10, I 
created a cell line harbouring a N-terminal in situ V5-tagged TbCNOT10, in 
addition to its inducible RNAi targeting TbCNOT10. Upon tetracycline 
induction, the protein level of V5-tagged TbCNOT10 decreased after one day 
(Figure 8 G).  
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Figure 8 RNAi screen targeting several subunits of the CAF1-NOT 
complex in T. brucei 
An RNAi screen was performed against all canonical (CAF40 and NOT2, 3/5) and potential 
(CAF16 and TbCNOT10) subunits of the CAF1-NOT complex in T. brucei (A-F). In the 
bloodstream form of the parasite, the proliferation experiment was conducted over a period of 
four days and in the procyclic form five days. (G) The protein amount of TbCNOT10 
decreased after one day of tetracycline induction, in both life stages of the parasite. 
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Through my experiments, I could show that TbCNOT10 is essential for the 
proliferation of the parasite in both life stages. Interestingly, this was also the 
case for NOT3/5 and CAF40. My decision to focus on TbCNOT10 relies on 
the fact that it differs a lot from its orthologues in other eukaryotes and is both 
a stable and an essential member of the complex. 
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V.4. Purification of recombinant TbCNOT10 
In order to raise an antibody and conduct enzymatic assays, TbCNOT10 
was N-terminal His-tagged and expressed in the E. coli strain BL21. The 
expression was induced by the addition of 0.1 mM IPTG two hours prior 
harvesting. His-tagged TbCNOT10 was not soluble under various conditions 
(e.g. different E. coli strains, cell densities, concentrations of IPTG, growth 
under various temperatures) and hence eluted under denaturing conditions, 
using the denaturing elution buffer supplemented with 300 mM Imidazole. The 
efficiency of the purification was very low and contained a lot of undesired 
protein contaminations beside the His-tagged TbCNOT10. Although high 
stringent elution conditions were applied, most of the recombinant protein 
remained bound to the beads. Figure 9 shows a representative purification 
attempt of His-tagged TbCNOT10. An attempt to express soluble TbCNOT10 
by using another plasmid system failed. This plasmid (pET-Trx, gift from AG 
Krauth-Siegel) encodes for a thioredoxin fusion protein, which is supposed to 
enhance the solubility of the expressed recombinant protein. Unfortunately, I 
was not able to see the expression of TbCNOT10 after the induction of IPTG.  
 
 
Figure 9 His-tagged TbCNOT10 purification 
His-tagged TbCNOT10 was purified under denaturing conditions from His-beads using an 
elution buffer containing an additional 300 mM Imidazole at pH 4.5. The protein was retrieved 
from the beads with a lot of contaminations (L=Ladder, FT=Flow through, W=Wash I-IV, 
B=Beads). 
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Considering the functionality and good expression of V5- and/or TAP-
tagged TbCNOT10, I decided to use them for all future experiments and stop 
with protein purification.  
 
V.5. TbCNOT10 is located in the cytoplasm 
In immunofluorescence microscopy, TAP-tagged TbCNOT10 was 
detected in a rather granular pattern in the cytoplasm (Figure 10).  
 
  
Figure 10 Immunofluorescence of N-terminal in situ TAP-tagged 
TbCNOT10  
TAP-tagged TbCNOT10 was detected by immunofluorescence. DAPI indicates the position of 
the Nucleus and Kinetoplast. Differential interference contrast (DIC) microscopy shows the 
parasite’s cell body. 
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V.6. TbCNOT10 is essential for proper mRNA 
turnover 
My next step was to analyse the effect of TbCNOT10 depletion on mRNA 
degradation. Three mRNAs (actin (ACT), histone H4 (HISH4) and EP 
procyclin (EP)) were analysed and in general, mRNA degradation was 
inhibited with chemical inhibitors (Figure 11 A, B, C). In TbCNOT10-depleted 
cells, the half-life of actin mRNA (ACT) was delayed by around 30 min and 
deadenylation was reduced as could be verified in the slower decrease of the 
bands’ size in comparison to wild-type. Moreover, the steady-state level of 
ACT increased 5.7-fold after TbCNOT10 depletion (Figure 11 A). When I 
looked at the mRNA of Histone H4 (HISH4), I could also observe an increase 
of its half-life, but both steady-state and deadenylation seemed to be 
unaffected (Figure 11 B). The half-life of EP was strongly deferred by over 90 
min, deadenylation reduced and the steady-state raised 3.5-fold (Figure 11 C) 
(58). These results are comparable to a knockdown of CAF1, although HISH4 
deadenylation was inhibited in CAF1-depleted cells (38). 
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Figure 11 mRNA degradation assay upon TbCNOT10 depletion 
TbCNOT10 was depleted for 36 h by RNAi in T. brucei. Then, transcription was inhibited by 
the addition of chemical inhibitors (Sinefungin, Actinomycin D) and followed by the collection 
of cells at 0, 30, 60 and 90 min. In (A, B, C) Northern Blots of mRNA degradation assays, 
analysing the degradation of ACT, HISH4 and EP, are shown for wild-type and TbCNOT10 
depleted cells. The obtained signals were normalised to rRNA. (A) The signal for ACT (each 
n=6) was quantified for wild-type and TbCNOT10 RNAi and results were plotted as mean. 
The dashed line and square box represent RNAi whereas diamonds and continuous line 
represent wild-type. The same was done for HISH4 (n=4) (B) and for EP (n=6) (C). In (C), the 
last time point for WT is not shown due to the degradation of EP. 
 
To assess if TbCNOT10 depletion influences only certain mRNAs or 
rather acts globally, I repeated the mRNA degradation assays. The isolated 
RNA, depleted of rRNA, was sent to the Deep Sequencing facility of the 
Bioquant for RNAseq. Additionally, I sequenced mRNA degradation assays 
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for CAF1-, PAN2- and RRP45-depleted cells. The RNAi efficiency was 
verified by Northern blots (Figure 12 A-D). 
 
 
Figure 12 RNAi verification of the analysed knockdown cell lines 
RNA samples were taken at each time point in order to assess the efficiency of the knockout. 
(A-D) show the Northern blots for each experiment. The Signal was normalised to 7 SL RNA. 
 
To normalise the received results for differences in e.g. RNA amounts 
and library preparation efficiency, I ran Northern blots with an aliquot of each 
sample and hybridised them with a radioactive labelled spliced leader oligo, 
as shown in Figure 13 A-E. In wild-type cells, 54 % of the total mRNA was left 
after 30 min of transcription inhibition (Figure 13 A). When I depleted the cells 
of CAF1, TbCNOT10 and RRP45 I could observe a stronger signal for bulk 
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mRNA, meaning that overall mRNAs became more stable. Knocking down 
PAN2 had only a minor effect (Figure 13 D). 
 
 
Figure 13 Spliced leader control for RNAseq samples 
An aliquot of each sample was loaded on a 1.5 % RNA-gel to determine the overall mRNA 
half-life. (A) shows the signal from the spliced leader at time point 0 and 30 min from wild-
type cells. Figures (B-E) show the signal from the spliced leader for time point 0 and 30 min 
for the knockdown cell lines CAF1, TbCNOT10, PAN2 and RRP45. 
 
The normalised RNAseq data showed that knocking down TbCNOT10 
led to a halt in mRNA degradation and increased the half-life of most mRNAs 
to over 60 min. The same result was obtained in CAF1- and RRP45-depleted 
cells, but RNAi targeting PAN2 had only a minor effect on the stability of 
mRNAs (Figure 14 - Abeer Fadda undertook all related bioinformatic and 
statistical analyses).  
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Figure 14 Overview of mRNA half-lives after RNAi 
The diagram shows the number of different open reading frames (ORFs) and their 
corresponding mRNA half-life. mRNAs from wild-type cells are coloured in orange, PAN2-
depleted cells in red, RRP45-depleted cells in blue, CAF1-deplted cells in green and 
CNOT10-depleted cells in purple. The box illustrates the efficiency of the RNAi, using the 
corresponding sequence reads of the knockdown and comparing them to WT. 
 
These results indicate that TbCNOT10 is important for proper 
deadenylation and mRNA degradation in T. brucei. As expected, CAF1 is 
essential for normal mRNA degradation, whereas PAN2 has no effect. 
Surprisingly, a knockdown of RRP45 inhibited mRNA degradation in the same 
way as an inhibition of deadenylation (Depletion of CAF1 and TbCNOT10) 
did. My next steps attempt to understand the role of TbCNOT10 in mRNA 
turnover. 
 
V.7. TbCNOT10 is essential for the interaction of CAF1 
with the major deadenylase complex 
To find out whether TbCNOT10 is necessary for the stability of the 
complex, I used glycerol gradient centrifugation to analyse it. For these 
experiments, I used mixtures of cell lysates from trypanosomes expressing 
V5-tagged versions of CAF1, NOT1 or cells expressing V5-tagged CAF1 
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depleted of TbCNOT10. CAF1, TbCNOT10 and NOT1 all migrated between 
fractions 9 to 20, with the major peak of the CAF1-NOT complex in fractions 
13 – 18. In addition, a major part of CAF1 was in the lighter fractions 2 – 8 
and hence not associated with the complex. When I knocked down 
TbCNOT10 by RNAi, CAF1 no longer co-migrated with the complex (Figure 
15 B). Quantification of 3 independent gradients clearly confirmed that CAF1 
was no longer associated with NOT1 after TbCNOT10 depletion (Figure 15 C 
and D).  
This result suggests that TbCNOT10 is essential for the interaction of 
CAF1 with the rest of the NOT complex. 
 
 
Figure 15 Glycerol Gradient of the CAF1-NOT complex of T. brucei 
(A) The extract of three different cell lines (in situ V5-tagged CAF1, TbCNOT10 and NOT1) 
were mixed and run on a 10 – 30 % Glycerol Gradient. The gradient was divided into 26 
fractions. The size indications are shown at the bottom of Figure (B). Figure (B) presents a 
Glycerol gradient of TbCNOT10-depleted cells and in situ V5-tagged CAF1. (C) shows the 
quantification of the signal of 3 independent gradients in percent (total mean signal) of V5-
CAF1 in TbCNOT10-depleted cells (dashed line; n=3) and control (black line; n=3). A 
comparison of the V5-CAF1 Western blot signal from fraction 10 – 20 is shown in (D). 
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V.8. TbCNOT10 depletion reduces the amount of 
NOT1 
To define the interactions within the Trypanosoma CAF1-NOT complex in 
more detail, Esteban Erben analysed them using the yeast two-hybrid system. 
Due to the large size of NOT1, we decided to analyse the N- and C-terminal 
portions separately. The experiments showed that TbCNOT10 directly 
interacted with CAF1, NOT5 and with the N- and C-terminal part of NOT1 
(Figure 16). The interaction between TbCNOT10 and NOT3/5 could be shown 
only with TbCNOT10 as the prey and NOT3/5 as the bait. CAF1 interacted 
with TbCNOT10 and the N-terminal part of NOT1, but not with NOT3/5. The 
interactions of CAF1 with the C-terminal part of NOT1 were shown only in one 
direction and only under low stringency conditions.  
 
 
Figure 16 Yeast two-hybrid interactions in the CAF1-NOT complex 
Left: Minus and plus signs indicate the absence or presence of interaction detected by the 
activation of the His3 and LacZ reporters; multiple pluses indicate the activation of the Ade2, 
His3 and LacZ reporters. Lamin and T antigen (7) are negative controls. Right: Illustration of 
the CAF1-NOT complex. Lines indicate interactions between different subunits; a dashed line 
means that the interaction could be proved in only one direction.  
 
To analyse whether TbCNOT10 depletion directly affects the amount of 
CAF1 or NOT1, I knocked down TbCNOT10 in cells expressing V5-CAF1 or 
V5-NOT1 over a period of 2 days and analysed protein levels by Western blot. 
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V5-CAF1 was not influenced by a depletion of TbCNOT10 (Figure 17 A, lane 
e.g. 3 and 4), but NOT1 was decreased (Figure 17 B, lane e.g. 3 and 4).  
 
 
Figure 17 TbCNOT10 knock down leads to decrease of NOT1 
(A) The level of in situ V5-tagged CAF1 was measured after TbCNOT10 depletion over a 
period of 2 days. (B) The effect of TbCNOT10 RNAi on in situ V5-tagged NOT1 was analysed 
in three different clones over a period of 2 days.  
 
To confirm the results, I analysed the interactions by co-
immunoprecipitation in cells with normal amount of TbCNOT10 and in 
TbCNOT10-depleted cells. First, I tried to determine if CAF1-myc and V5-
CAF40 could pull each other down. In cells with normal amounts of 
TbCNOT10, precipitation of CAF1-myc resulted in coprecipitation of V5-
CAF40 (Figure 18 A lane 6), but this no longer occurred in cells depleted of 
TbCNOT10 (Figure 18 A lane 9). The results were confirmed by reciprocal 
pull-down (Figure 18 B lane 6 and 9). I further analysed the association of 
CAF1 and NOT1 by co-IP, to see if the interaction is TbCNOT10-dependent. 
In V5-NOT1 and inducible CAF1-myc cells, a pull-down of CAF1-myc yielded 
V5-NOT1 as interaction partner (Figure 18 C lane 6), but CAF1-myc could not 
coprecipitate NOT1 in CNOT10-depleted cells (Figure 18 C lane 9). In cells 
with normal levels of TbCNOT10, co-IP of V5-tagged NOT1 resulted in CAF1-
myc pull-down (Figure 18 D lane 6). However, when I knocked down 
TbCNOT10 and V5-NOT1 was pulled down, there was only a slight reduction 
of the interaction between CAF1 and NOT1 (Figure 18 D 9). So far, I was 
unable to account for this discrepancy but my hypothesis is that all remaining 
NOT1 is the fraction that is bound to CAF1. 
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Figure 18 Depletion of TbCNOT10 reduces CAF1 association with the 
complex  
1% was loaded for input (I) and supernatant (S) and the rest was eluted (E). (A) anti myc-
beads were used to pull-down myc-tagged CAF1 in wild-type cells (lanes 4-6) and cells with 
TbCNOT10 RNAi (lanes 7-9). Cells expressing V5-tagged CAF40 alone (lanes 1-3), without 
myc-tagged CAF1, were used as a negative control. Figure (B) shows the reciprocal 
experiment using V5-beads. (C, D) as in (A, B) respectively, but here the interaction between 
CAF1 and NOT1 was analysed with or without TbCNOT10 RNAi.   
 
The yeast two-hybrid experiments showed that both CAF1 and TbCNOT10 
directly interact with NOT1. Moreover, TbCNOT10 is probably important for 
the stability of NOT1, and for the interaction between CAF1 and NOT1. 
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V.9. CAF1 deadenylation activity is not complex-
dependent 
My results so far suggested that in vivo, when CAF1 is not in the NOT 
complex, CAF1 is unable to initiate mRNA degradation. However, our lab had 
previously shown that recombinant CAF1 is active in deadenylation in vitro 
(38). There are two possible explanations for this discrepancy. Either CAF1 
enzyme activity in vivo might be complex-dependent, or CAF1 relies on the 
complex for attachment to substrates. To distinguish these possibilities, I used 
a cell line containing a constitutively-expressed mRNA reporter that consisted 
of a GFP ORF followed by six boxB elements and an actin 3’UTR. In addition, 
the cell line inducibly expressed a CAF1 fusion protein with a λN peptide at 
the N-terminus and myc at the C-terminus (λN-CAF1-myc). As expected, 
upon induction of λN-CAF1-myc expression, GFP-boxB mRNA was destroyed 
(Figure 19, lane 1, 2 and 7, 8). Control RNA with no boxB was unaffected by 
λN-CAF1-myc expression (not shown). However, I cannot exclude that in the 
experiment, tethered CAF1 might still interact with the NOT complex. 
Therefore, I depleted TbCNOT10 by RNAi in order to eliminate the interaction 
and thus, CAF1 alone should be tethered. Nevertheless, tethered CAF1 still 
induced the degradation of the GFP-boxB mRNA reporter (Figure 19, lane 3,4 
and 5,6 as well as 9,10 and 11,12). This suggests that CAF1 alone is indeed 
active in vivo (as expected from in vitro activity), but that it depends on the 
presence of TbCNOT10 to be recruited to its substrate. However, RNAi is 
never 100 % efficient and hence TbCNOT10 might not be depleted sufficiently 
to stop degradation.  
The results indicate that TbCNOT10 is essential for the recruitment of CAF1 
to mRNAs, but is not responsible for it. 
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Figure 19 Tethering CAF1 to a GFP reporter mRNA 
(A) The illustration shows the reporter mRNA used in this experiment. The cap structure of 
the mRNA is indicated in grey and the GFP ORF in green. A 6 B-box loops resides at the 
start of the ACT 3’UTR. (B) λN-CAF1 myc-tagged is shown in red and TbCNOT10 in orange. 
(C) shows Western and Northern blots of GFP protein (above) and GFP mRNA. The Western 
blots also show the inducible expression of λN-CAF1-myc as well as Aldolase control. In the 
Northern blots below, TbCNOT10 mRNA is shown and rRNA was used as a loading control. 
(D) In the parental cell line ((C) P – lane 1,2,7,8) λN-CAF1-myc is tethered to the GFP 
reporter mRNA, upon tetracycline induction due to their interaction through the λN peptide 
and the 6 B-box loops respectively. λN-CAF1-myc interacts with the NOT complex and is able 
to degrade the reporter. (E) In cell line A and B, TbCNOT10 is diminished upon RNAi for 1 
((C) lane 4,6) and 2 days ((C) lane 10,12). CAF1 is still tethered to the reporter RNA and can 
still degrade poly(A), even though association with the NOT complex has decreased. (Parts of 
this figure were prepared by Prof. CE Clayton) 
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V.10. HsCNOT10 is not required for the association of 
CAF1 with the major deadenylation complex 
Given the importance of TbCNOT10 in mRNA degradation, I became 
interested in finding out if its function was conserved in mammalian cells. 
Therefore, I collaborated with Sahil Sharma from the Stoecklin Group of the 
DKFZ, who first confirmed the interaction of HsCAF1a and HsCNOT10 in 
human embryonic kidney (HEK) 293 cells by co-immunoprecipitation (Figure 
20 A). Using myc-strep-tagged HsCAF1a, he was able to pull-down 
HsCNOT10 and could confirm the interaction previously shown by tandem 
affinity purification (162). To find out whether the association of HsCAF1a with 
the human CCR4-CAF1-NOT complex is CNOT10-dependent, he knocked 
down HsCNOT10 by siRNA and used a scrambled siRNA as well as a siRNA 
targeting HsNOT1 as controls. Together, we analysed the migration of 
HsCAF1a in a glycerol gradient. Figure 20 B shows that HsCNOT10 depletion 
did not influence the migration of HsCAF1a, while a knockdown of HsNOT1 
led to a shift of HsCAF1a towards lighter fractions. The knockdown efficiency 
of HsCNOT10 and HsNOT1 was verified by Western Blot analysis (Figure 20 
C). 
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Figure 20 Co-immunoprecipitation of HsCAF1 and HsCNOT10 and 
glycerol gradients of HsCAF1 
(A) Using myc-strep-tagged HsCAF1a, we were able to pull-down HsCNOT10 in HEK cells. 
(B) Control, human CNOT10 and NOT1 RNAi extracts were run on a 10 – 30 % glycerol 
gradient and 15 fractions were collected. The Western blots of the gradients were analysed 
for the migration of HsCAF1a. Knock down of HsCNOT10 did not affect the migration of 
HsCAF1a, but a knock down of HsNOT1. (C) The knock down efficiency for HsNOT1 and 
HsCNOT10 was verified by Western blots. 
 
The results suggest that HsCNOT10 is not required for association of 
HsCAF1 with HsNOT1 in mammalian cells. 
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VI. Discussion 
The CAF1-NOT complex is responsible for most deadenylation in T. 
brucei. In a previous study conducted in our lab, CAF1 was identified as the 
major deadenylase in trypanosomes (38), and it is known that NOT1 acts as 
the major scaffold of the complex (76, 163). The aim of my PhD was to 
identify the essential subunits of the complex and their subsequent 
characterization. My decision to characterise TbCNOT10 was based on the 
fact that this subunit is essential for proliferation of the parasite and differs 
greatly from its orthologues in other eukaryotes. 
 
VI.1. CNOT10 is an essential cytoplasmic subunit of the CAF1-
NOT complex in trypanosomes 
A tandem affinity purification of CAF1 revealed known (NOT1, NOT2, 
NOT3/5, DHH1) and putative (CNOT10-like protein, CAF16) subunits of the 
CAF1-NOT complex in trypanosomes (38). Several in silico results confirmed 
that Tb927.10.8720 is an orthologue of CNOT10. Moreover, TbCNOT10 has a 
Tetratrico peptide repeat (TPR)-like domain comparable to its counterpart in 
other eukaryotes. The retrieved e-values (below 3e-04 to 1e-07) to potential 
orthologues were good and a reciprocal blast search of CNOT10 in human 
and trypanosome always showed CNOT10 as the first hit. Beside the in silico 
data, the co-IP of CAF1 and CNOT10 confirmed that it is a stable member of 
the CAF1-NOT complex. The fact, that CAF1 could only partially pull-down 
CNOT10 (and vice versa) is no surprise. Indeed, the results of the glycerol 
gradient experiments showed that around 50 % of CAF1 was not bound to the 
NOT complex in trypanosomes. Moreover, N-terminal protein-A-calmodulin-
binding-peptide tag CNOT10 could pull-down all core subunits of the CAF1-
NOT complex, except CAF1. This is not surprising considering the amount of 
unbound CAF1 in the cell. In a TAP of HsCNOT10 bearing a N-terminal 
FLAG-HA tag, the same results were obtained (67). In this study, CAF1a 
could be pulled down by CNOT2, CNOT3, CNOT6 (CCR4) and CNOT9 
(CAF40). Our glycerol gradients in HEK cells also indicate that a fraction of 
human CAF1a is not bound to the complex even though glycerol gradients 
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with HeLa cells gave a different result (79). The discrepancy between the cell 
lines might be explained by fact that the human CCR4-CAF1-NOT complex 
seems to exhibit a tissue-specific expression pattern (69, 88).  
The immunofluorescence microscopy experiments showed that TAP-
tagged TbCNOT10 reside in the cytoplasm like other subunits of the complex 
(38). However, the TAP-tag (N-terminal protein-A-calmodulin-binding-peptide) 
prevented colocalisation experiments to further analyse the rather granular 
pattern and the signal for V5-tagged CNOT10 was below the detection limit. 
To solve this issue, one could conduct further experiments with other tags 
(myc-tag or GFP fusion protein) or raise an antibody. The tags can never 
represent the native state of the protein in the cell and hence it is necessary to 
continue the efforts in raising an antibody against TbCNOT10 in order to 
further characterise its location. None of the efforts in purifying a recombinant 
protein led to a satisfactory expression. Moreover, after stringent washing 
conditions under denaturing conditions, N-terminal His-tagged CNOT10 
remained on the column. This behaviour could be on account of the TPR–like 
domain, which is known to be involved in protein-protein interaction (164) and 
hence might be responsible for the increased adherence to the resin. Thus, 
cloning only a N-terminal fragment of TbCNOT10 lacking the TPR-domain 
could be a possible solution. To overcome the solubility issue, I have tried 
several recommended actions, e.g. expression at different temperatures, cell 
density, using different plasmids (pET-Trx), etc., but none of these attempts 
proved successful. However, one could try to increase the solubility by adding 
charged amino acids (L-Arg and L-Glu) as recommended by Golovanov et al. 
in 2004 (165). I decided to work with only the tagged-versions (V5 or TAP) of 
CNOT10, because the purification of the recombinant protein demanded too 
much time and, more importantly, I could show that the tagged TbCNOT10 
(V5 or TAP) were functional, by deleting the remaining wild-type copy.  
The RNAi screen against subunits of the CAF1-NOT complex (CAF16, 
CAF40, CNOT10, NOT2, NOT3/5) revealed that almost all investigated 
proteins are essential for the growth of the parasite except for the CAF16-like 
protein and NOT2. In regards to the putative CAF16, I did not observe any 
signal on the Northern blot and hence could not confirm the efficacy of the 
knockdown. The signal might have been masked by the rRNA signal, which 
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runs at the same place on the Northern blot. A poly(A) tail purification of the 
total RNA might have led to an enrichment of the signal, but in silico studies 
revealed that the gene locus Tb927.6.2810 encodes for a putative ABC 
transporter and not for CAF16 so I did not proceed. For NOT2, the RNAi 
efficiency was very low in all studied clones. Nevertheless, a RNAi screen by 
Alsford et al. in 2011 also showed no growth defect for Tb927.6.2810 
(putative ABC transporter) and NOT2 (161). 
 
VI.2. The role of exoribonucleases and TbCNOT10 
in mRNA turnover 
Depletion of TbCNOT10 led to an increase of the steady-state levels of EP 
and ACT, two unstable mRNAs, but not that of HISH4. This is comparable to 
a knockdown of CAF1 although its depletion only led to an increase of the 
steady-state level from EP (38, 58). The elevation of ACT’s steady-state 
triggers new questions. In yeast, it was indicated that steady-state levels of 
RNAs transcribed by RNA Pol II remain stable due to a feedback response 
(166). In S. cerevisiae, Rpb4p and Rpb7p, two subunits of RNA Pol II, were 
shown to shuttle mRNAs out of the nucleus by binding to them. Once in the 
cytoplasm, Rpb4/7p stimulates degradation of the bound RNAs by inducing 
deadenylation and recruiting the Pat1/Lsm1-7 complex (167, 168). A recent 
genome-wide transcriptome study in yeast, that used a mutant of Pol II 
leading to a poor recruitment of Rpb4/7p, proposed an explanation to the 
mechanism behind the feedback loop. They suggested that the proportion of 
Rpb4/7p-bound mRNAs and unbound mRNAs may change depending on the 
situation of the cell (166). In the case of CAF1-depleted trypanosomes, this 
would mean that the amount of transcripts that are shuttled out by Rpb4/7 
increases. However, this no longer holds true when TbCNOT10 is depleted. In 
this case, it seems that either Rpb4/7 depends on TbCNOT10 to stable 
associate with certain transcripts or Rpb4/7-coated transcripts are simply not 
degraded in the absence of TbCNOT10. In both case, the lack of TbCNOT10 
allows the steady-state level of some transcripts to increase. 
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The genome of T. brucei possesses putative homologues of Rpb4 
(Tb927.3.5270) and Rpb7 (Tb11.01.6090) and the role of these subunits in 
transcriptions is still under discussion (169-173). In addition, the RNAi screen 
by Alsford showed that they are only essential in the bloodstream form (161), 
which indicates either that these subunits do not contribute to a general 
feedback loop in T. brucei or that this feedback loop is only present in the 
bloodstream form of the parasite. However, TbCNOT10 was depleted in 
bloodstream cells and the steady-state levels still rose, which implicates that 
there must be different feedback mechanisms involved in the regulation of the 
steady-level of mRNA transcripts. For example, mRNA transcription might 
depend on the ribonucleotides provided by mRNA decay and thus, once 
mRNA decay stops, the steady-state level remains unchanged because no 
further transcripts can be provided due to a lack of ribonucleotides. This might 
also explain why only some RNAs show increased steady-state levels. 
Indeed, mRNA turnover did not completely stop in the RNAi mutants, thus 
permitting transcription to continue since ribonucleotides were still provided by 
mRNA decay. Therefore, it would be interesting to further study the effect of 
the knockdown mutants on steady-state. 
 
In the case of EP in particular, it was clear that deadenylation was slowed 
down in CNOT10-depleted cells because full-length mRNAs were still visible 
even after 90 min. The bulk mRNA turnover experiments (Northern blots with 
spliced leader and RNAseq) showed that TbCNOT10 depletion leads to a halt 
in mRNA degradation, similar to a knock down of CAF1 and RRP45. The less 
efficient RNAi of CAF1 might explain the differences between CAF1 and 
CNOT10. PAN2 depletion did not have an effect on bulk mRNA turnover, 
indicating that the CAF1-NOT complex might be able to compensate its lack. 
The observation that the PAN2-PAN3 complex is not essential in yeast and 
got lost in many organisms during evolution (58) also indicates that its 
function can be replaced. The major effect of RRP45 knockdown was rather 
surprising because one can suspect that not all mRNAs are degraded through 
the 3’->5’ degradation pathway (8, 58). Previous studies have shown that in T. 
brucei, mRNA degradation can occur from both ends, that is to say either by 
XRNA or the exosome (58, 147). The evidence for this was based on the 
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observation that an EP RNA reporter showed polyadenylated degradation 
products and that degradation was inhibited in XRNA-depleted cells (58). In 
the same study, deadenylated EP reporter RNA intermediates could also be 
detected, thus proving the existence of a 3’ – 5’ degradation pathway. The 
results showed that degradation of EP involves a fast XRNA-dependent 
component and another one, slower and CAF1-dependent. However, a 
genome-wide transcriptome study, with XRNA knockdown mutants, showed 
that the main role of XRNA is in the degradation of unstable RNAs (8) and 
hence trypanosomes might degrade most RNAs by 3’->5’ degradation 
pathway with the exosome. Nevertheless, further computational and 
experimental studies are needed. 
 
VI.3. TbCNOT10 is essential for the association of CAF1 with the 
NOT complex and its recruitment to mRNAs 
TbCNOT10 interacted directly with CAF1, NOT3/5 and with both the N- 
and C-terminal halves of NOT1 (Figure 16), which is similar to the interactions 
of CAF130 with NOT1 in yeast (83). Unlike TbCNOT10, neither CAF130 nor 
human CNOT10 seem not to be essential for the integrity of the complex (77, 
this thesis). Although, I cannot exclude interactions via yeast NOT complex 
proteins, this idea seems rather unlikely since CNOT10 is absent in yeast. 
Surprisingly, it was seen that TbCNOT10 and CAF1 interact with themselves, 
which is an indication that they might dimerize. This could be a further 
mechanism to regulate the activity of the complex, ensuring for instance that 
monomer CAF1 can only interact with the complex but not with dimerized 
CAF1. 
Glycerol gradient analysis showed that about 50 % of V5-tagged CAF1 
was not bound to the NOT complex. After CNOT10 depletion, the association 
of V5-tagged CAF1 to the complex was further diminished and, as mentioned 
above, mRNA turnover came to a halt. One can only speculate about the role 
of unbound CAF1, but one possibility is that it acts deadenylation-
independently and represses translation as shown for Xenopus oocytes (174). 
Another possibility is that (unbound) CAF1 serves as a stock for newly formed 
NOT-complexes. Moreover, the depletion of TbCNOT10 led to a reduction of 
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V5-NOT1 protein level. Thus, TbCNOT10 seems to be essential for the stable 
interaction of CAF1 and NOT1, by interacting with each of them. The loss of 
CAF1 from the complex might lead to a structural change in NOT1, which 
could lead in turn to its degradation.  
The reduction in deadenylation in TbCNOT10-depleted cells led me to the 
assumption that in vivo free CAF1 by itself is unable to digest PABP-coated 
poly(A) tails. The easiest explanation for this observation is that CAF1 alone 
cannot be recruited to mRNAs. This is similar to in vitro experiments were the 
yeast CCR4-CAF1-NOT complex was not able to deadenylate PABP coated 
mRNAs (85). In contrast, once CAF1 is attached to mRNAs, either via the 
complex or by tethering, CAF1 is able to digest them. Similarly, in human cells 
depletion of NOT1 or NOT2 destabilised the CCR4-CAF1-NOT complex and 
decreased deadenylation activity in the cell (76, 79). 
In our tandem affinity purification of TbCNOT10, we did not identify RNA 
binding proteins that might be responsible for the recruitment of the complex 
to mRNAs. This is not surprising since the CAF1-NOT complex presumably 
interacts with many different proteins. Thus, RNA binding proteins might be 
underrepresented and/or interact only transiently with the NOT complex. A 
yeast two-hybrid screen with TbCNOT10 as bait and a genomic library as 
prey could identify them. Moreover, TbCNOT10 does not posses any known 
RNA binding domain, which would be necessary for a direct recruitment to 
mRNAs. Potential candidates for CAF1 recruitment might be CNOT3/5 and 9, 
which could pull-down several RNA binding proteins (e.g. TOB1, TOB2 and 
several zinc fingers) in HeLa cells (67). 
 
VI.4. Function of CNOT10 is not conserved in evolution 
In HEK cells, HsCNOT10 is not needed for the stable association of 
HsCAF1 with the NOT complex. Although HsCNOT10 interacted with 
HsCAF1a, its knockdown did not lead to a dissociation of HsCAF1a from the 
complex, which was however achieved by a knockdown of HsNOT1. This 
might be due to functionally redundant subunits, which compensate for the 
absence of HsCNOT10. A major difference between human and 
trypanosomes, in this respect, is the gain of CCR4, TAB182 and C2ORF29 in 
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humans, which might stabilise the interaction of HsCAF1 and NOT1 in the 
case of HsCNOT10 depletion. Another possibility is that HsCNOT10 is not 
needed for association of HsCAF1 in the kidney, but in other tissues, since 
the expression pattern of subunits of the CCR4-CAF1-NOT complex is tissue-
specific (69, 88). HsCNOT10 might also help to target certain RNAs in the 
cell, but the role of HsCNOT10 remains to be investigated. 
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VII. Current model and outlook 
My results suggest that, in trypanosomes, TbCNOT10 is important for the 
association of CAF1 with the NOT complex and its recruitment to mRNAs. It 
functions as follows: TbCNOT10 is essential for the interaction of CAF1 with 
NOT1 and the integrity of NOT1. If TbCNOT10 is depleted, CAF1 dissociates 
from the complex and loses its potential to bind mRNAs. Both the reduction of 
TbCNOT10 and the dissociation of CAF1 lead to degradation of NOT1 (Figure 
9). 
 
 
 
The role of TbCNOT10 in the process of mRNA turnover 
Left: In the absence of TbCNOT10, CAF1 is not able to bind PABP-covered mRNAs and 
initiate mRNA degradation. Therefore, TbCNOT10 is essential for CAF1’s complex 
association and subsequent mRNA degradation. Right: Upon association with the complex, 
CAF1 is “tethered” to target mRNAs and some other subunits of the complex. Now it is able to 
degrade its target mRNA. 
 
My study helped to broaden the understanding of mRNA turnover in T. brucei, 
but also triggered new questions. It is know that, in eukaryotic cells, the 
CCR4-CAF1-NOT complex can be recruited to mRNAs by RNA-binding 
proteins (74). In trypanosomes, no RNA-binding protein was identified to fulfil 
this role so far. The tandem affinity purification done for TbCNOT10 did not 
reveal any RNA-binding proteins but a genome-wide yeast two-hybrid screen 
could find them. Thus, it would be interesting to include all other core subunits 
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of the complex (CAF1, NOT1, NOT2 and NOT3/5) in a genome-wide yeast-
two hybrid screen in order to find all possible interaction partners of the 
complex. This would help to understand how the enzymatic activity of the 
major deadenylation complex is regulated. Another interesting experiment 
would be to tether TbCNOT10 to a reporter mRNA in order to see if it is 
degraded. This would prove that TbCNOT10 is able to recruit a functional 
CAF1-NOT complex. In the same line of thinking, it would also be interesting 
to see if TbCNOT10 might bind directly to RNAs and hence might directly 
recruit the complex to its substrate. Although TbCNOT10 does not contain 
any known RNA-binding domain, it was already shown that Pat1b could bind 
to RNAs without possessing any known domain (175, 176). To study the 
RNA-binding capacity of TbCNOT10, recombinant protein need to be 
produced and tested with different RNA oligos in electrophoretic mobility shift 
assays (EMSA). 
To study the role of HsCNOT10, one should efficiently knock down 
HsCNOT10 and analyse the degradation of a reporter mRNA. It would be 
interesting to see the impact of HsCNOT10 depletion on deadenylation, 
steady-state levels and mRNA half-life. To identify if HsCNOT10 is involved in 
RNA targeting, one should study its interaction partners by a yeast-two hybrid 
screen. 
Finally as to better understand the interactions within the major 
deadenylation complex, it would be interesting to try to crystallise it. 
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IX. Abbreviations 
ARE   AU-rich element  
Blast   Basic Local Alignment Search Tool 
BS   Bloodstream 
BSA   Bovine serum albumin 
°C   degree celsius 
CAF1   CCR4 associating factor 1 
CCR4   Carbon catabolite repressor protein 4 
CDS   Coding sequence 
DNA   Deoxyribonucleic acid 
DTT   Dithiothreitol 
ECL   Enhanced chemical luminescence 
GFP   Green fluorescence protein 
HEK   Human embryonic kidney 
HeLa   Henrietta Lacks  
Hs   Homo sapiens 
h   Hour 
kb   Kilo base 
kDa   Kilo Dalton 
l   Liter 
µ   Micro 
m   Milli 
min   Minute(s) 
miRNA  Micro RNA 
ml   Mililiter 
mRNA  Messenger RNA 
mRNP  Messenger ribonuleoprotein  
n   Nano 
NMD   Nonsense mediated decay 
NOT   Negative on TATA 
nt   Nucleotide 
ORF   Open reading frame 
PABP   Poly(A) tail binding protein 
PAN   Pab1p-stimulated poly(A) ribonuclease 
PARN   Poly(A)-ribonuclease 
P-body  Processing body 
PBS   Phosphate buffered saline 
PC   Procyclic 
PCR   Polymerase Chain Reaction 
Puf   Pumilio/Fem-3-binding factor 
RBP   RNA binding protein 
re   Recombinant 
RISC   RNA-induced silencing complex 
RNA   Ribonucleic acid 
RNAseq  RNA sequencing 
RRM   RNA Recognition motif 
RT   Room temperature 
SDS-PAGE  Sodium dodecyl sulfate polyacrylamid gel 
siRNA   Short interfering RNA 
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SL   Spliced leader 
SRP   Signal recognition particle 
SSC   Saline-sodium citrat 
TAP   Tandem affinity purifcation 
Tb   Trypanosoma brucei 
TBS-T   Tris-Buffered Saline and Tween 20 
TCA   Trichloroacetic acid 
TPR    Tetratrico peptide repeat  
TTP    Tristetraprolin 
TRAMP   Trf4/5-Air1/2-Mtr4 polyadenylation complex 
UTR   Untranslate region 
V   Volt 
VSG   Variant surface glycoprotein 
XRN1   Exoribonuclease 1 
XRNA   Exoribonuclease A 
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